Utah Retirement Systems Bluebird Bio, Inc. Transaction History

Utah Retirement Systems

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$16.59 - $33.89 $218,855 - $447,076	-13,192 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $16,500 - $22,752	600 Added 4.76%	13,192 $571,000
Q3 2020 Nov 16, 2020	BUY	$34.44 - $43.75 $10,332 - $13,125	300 Added 2.44%	12,592 $679,000
Q2 2020 Aug 13, 2020	BUY	$27.12 - $45.97 $48,816 - $82,746	1,800 Added 17.16%	12,292 $750,000
Q4 2019 Feb 12, 2020	BUY	$46.96 - $61.67 $4,696 - $6,167	100 Added 0.96%	10,492 $921,000
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $12,589 - $17,464	166 Added 1.62%	10,392 $1.32 Million
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $8,119 - $13,117	126 Added 1.25%	10,226 $1.61 Million
Q3 2018 Nov 13, 2018	BUY	$88.86 - $117.49 $71,088 - $93,992	800 Added 8.6%	10,100 $1.48 Million
Q2 2018 Aug 10, 2018	BUY	$99.64 - $127.59 $926,652 - $1.19 Million	9,300 New	9,300 $1.46 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

Stay updated on Utah Retirement Systems with notifications on news.